Moving Stocks: Cubist Pharmaceuticals Inc. (NASDAQ:CBST), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Riverbed Technology, Inc. (NASDAQ:RVBD), eHealth, Inc. (NASDAQ:EHTH), IDEX Corporation (NYSE:IEX)

Merck (MRK) announced it’s buying the Cubist Pharmaceuticals Inc. (NASDAQ:CBST) for $102 per share. Cubist Pharmaceuticals Inc. does advanced antibiotic research and is noted for its research on superbugs — diseases that have developed immunity to antibiotic treatment. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) belongs to Healthcare sector. Its net profit margin is 5.60% and weekly performance is 0.94%. On last trading day company shares ended up … Continue reading Moving Stocks: Cubist Pharmaceuticals Inc. (NASDAQ:CBST), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Riverbed Technology, Inc. (NASDAQ:RVBD), eHealth, Inc. (NASDAQ:EHTH), IDEX Corporation (NYSE:IEX)

Today’s Hot List: IAC/InterActiveCorp (NASDAQ:IACI), Micron Technology, Inc. (NASDAQ:MU), Ecopetrol SA (NYSE:EC), Cypress Semiconductor Corporation (NASDAQ:CY), Cubist Pharmaceuticals Inc. (NASDAQ:CBST)

Credit Suisse reaffirmed their outperform rating on shares of IAC/InterActiveCorp (NASDAQ:IACI) in a report issued on Thursday. They currently have a $72.00 target price on the stock, down from their previous target price of $76.00. IAC/InterActiveCorp (NASDAQ:IACI) belongs to Technology sector. Its net profit margin is 14.00% and weekly performance is -1.06%. On last trading day company shares ended up $64.30. IAC/InterActiveCorp (NASDAQ:IACI) distance from … Continue reading Today’s Hot List: IAC/InterActiveCorp (NASDAQ:IACI), Micron Technology, Inc. (NASDAQ:MU), Ecopetrol SA (NYSE:EC), Cypress Semiconductor Corporation (NASDAQ:CY), Cubist Pharmaceuticals Inc. (NASDAQ:CBST)

Trending Tickers: Cubist Pharmaceuticals (NASDAQ:CBST), Cempra (NASDAQ:CEMP), Meridian Bancorp (NASDAQ:EBSB), Point.360 (NASDAQ:PTSX), Taminco (NYSE:TAM)

Cubist Pharmaceuticals Inc (CBST) announced yesterday, it is recalling 101 production lots of its antibiotic Cubicin (daptomycin injection) amid fear of glass particles being present in the drug. Cubicin, which is intravenously administered, is used to treat blood and skin infections. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) belongs to Healthcare sector. Its net profit margin is 0.70% and weekly performance is 0.58%. On last trading day company … Continue reading Trending Tickers: Cubist Pharmaceuticals (NASDAQ:CBST), Cempra (NASDAQ:CEMP), Meridian Bancorp (NASDAQ:EBSB), Point.360 (NASDAQ:PTSX), Taminco (NYSE:TAM)